Qiagen Launches RNAi and qPCR-Based Gene Expression Assays

Qiagen, a provider of innovative enabling technologies and products for the separation, purification and handling of nucleic acids and proteins, announced the launch of what it believes is the world's first and largest product portfolio for integrated genome-wide RNAi and SYBR Green-based RT-PCR (reverse transcriptase polymerase chain reaction). The offering addresses a critical need in research and drug development. Qiagen believes that this new offering represents a substantial improvement over current offerings and that it provides access to a new dimension of value for customers in the rapidly growing field of RNAi.

Canada NewsWire (http://www.newswire.ca/en/releases/archive/April2005/21/c8342.html)